Venous thromboembolic complications in patients with malignant glioma treated on a bevacizumab clinical trial.

9090 Background: Although the prognosis for malignant glioma remains poor, the introduction of bevacizumab has improved survival for patients with this devastating illness. Bevacizumab is a humaniz...